Related Experiment Videos
CD7-positive acute myeloid leukemia: further evidence of cellular immaturity
1First Department of Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Abstract:
Among 63 cases of acute myeloid leukemia (AML), 14 were found to express the CD7 antigen, a cell surface marker usually found at an early stage during T lineage differentiation. The CD7-positive AML cases consisted of 5 cases of M1, 3 cases of M2, 3 cases of M4, 1 case of M5, 1 case of M6 and 1 case of M7. Among these 63 cases, the proportion of blast cells expressing the CD34 antigen was examined. The proportion of CD34-stained cells among the CD7-positive AML cases, although varying, was significantly larger than that among the CD7-negative AML cases (P less than 0.05). As the CD34 antigen was expressed on hematopoietic progenitor cells and was considered to reflect an early hematopoietic stage, the high proportion of cells expressing CD34 among the CD7-positive AML cases may support the notion that CD7-positive AML cells are immature.
Insights
CD7 antigen expression in acute myeloid leukemia (AML) is linked to immature cells. CD7-positive AML cases showed a higher proportion of CD34 antigen, indicating an early hematopoietic stage.
Area of Science:
- Hematology
- Immunophenotyping
- Leukemia Research
Background:
- Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies.
- CD7 is a cell surface marker typically associated with early T-cell lineage differentiation.
- The immunophenotypic profile of AML can provide insights into its biology and prognosis.
Purpose of the Study:
- To investigate the expression of CD7 antigen in a cohort of AML cases.
- To determine the correlation between CD7 expression and the proportion of CD34-positive blast cells in AML.
- To explore the implications of CD7 expression for the immaturity of AML cells.
Main Methods:
- Analysis of 63 cases of acute myeloid leukemia (AML).
- Immunophenotyping to detect CD7 and CD34 antigen expression on leukemic blast cells.
- Statistical comparison of CD34 expression levels between CD7-positive and CD7-negative AML cases.
Main Results:
- Fourteen out of 63 AML cases (22.2%) expressed the CD7 antigen.
- CD7-positive AML cases included various FAB subtypes (M1, M2, M4, M5, M6, M7).
- A significantly higher proportion of CD34-positive cells was observed in CD7-positive AML compared to CD7-negative AML (P < 0.05).
Conclusions:
- CD7 expression in AML is associated with a higher proportion of CD34-positive cells.
- The co-expression of CD7 and CD34 suggests an immature phenotype in these AML cells.
- CD7 positivity may serve as a marker for immature myeloid blasts in a subset of AML patients.